Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet

Transplantation. 2024 Jan 1;108(1):7-9. doi: 10.1097/TP.0000000000004809. Epub 2023 Dec 13.

Authors

Matthew B Roberts¹, Camille N Kotton^{2

3}

Affiliations

¹ Infectious Diseases Unit, Royal Adelaide Hospital, Adelaide, Australia.
² Infectious Diseases Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.
³ Department of Medicine, Harvard Medical School, Boston, MA.

PMID: 38098156
DOI: 10.1097/TP.0000000000004809

No abstract available

MeSH terms

Acetates / therapeutic use
Antiviral Agents / therapeutic use
Cytomegalovirus Infections* / drug therapy
Hematopoietic Stem Cell Transplantation*
Humans
Kidney Transplantation* / adverse effects
Quinazolines

Substances

Antiviral Agents
Acetates
letermovir
Quinazolines